Compartmentalisation

Tidy up your cells

Dynamic spatial organisation at all levels is a universal property of living systems [26]. Contemporary cells, both eukaryotes and prokaryotes, rely on compartmentalisation. In eukaryotes, compartmentalisation relies on intracytoplasmic membrane systems, for example, chloroplasts, mitochondria, vacuoles and the cell nucleus, allowing metabolic processes to be specifically localised and controlled [27][28]. For a very long time, bacterial cells were considered to be simple cells with hardly any spatial division. However, recent research has shown that they also exhibit subcellular differentiation [29]. The majority of prokaryotes use membrane-less, protein-based compartments to spatially control metabolism. Encapsulation can lead to the creation of unique microenvironments in regard to, redox state, pH and ionic strength [27]. Bacteria have to overcome many hurdles in the course of a pathway. First, the enzymes involved must be present in the correct stoichiometry. Secondly, intermediates can diffuse through the cell membrane. Third, intermediates produced in the biosynthetic pathway can be toxic to the cell. Furthermore, inhibitors of enzymes can occur, intermediates can be unstable, or intermediates can be used for other pathways [5][30].

To deal with these problems, nature has found a solution, compartmentalization. Enzymes can be brought together in the right amount, intermediates do not diffuse out of the cell as easily, toxicity is reduced by shielding and rapid conversion to the next product, inhibitors and competing enzymes are more likely to be excluded, in short, compartmentalization can improve the yield of several pathways [5][30][31].

For our project we worked with three different systems of compartmentalization (Figure 1).

Types of compartmentalization.

Figure 1: Types of compartmentalization. Bacterial microcompartment shells derived from Haliangium ochraceum (HO-Shells) and encapsulin nanocompartments have rigid structures and Spd-5 proteins behave like liquid droplets when aggregated.

1. Bacterial microcompartments (BMCs) are self-organising organelles with a selectively permeable protein shell. All BMCs consist of three conserved families of proteins: BMC-H (forming hexamers), BMC-T (pseudohexamers) both with pores of different sizes in the middle and BMC-P (pentamers) [4][32]. Small molecules can enter the lumen of BMCs via the pores found within the BMC-H shell proteins (which vary in size from 4 - 7Å in diameter) or the larger pores (~12 - 14 Å in diameter) formed by BMC-T trimers which can have an open or closed confirmation [33][34]. For our project, we used the recently published synthetic BMCs from Kirst et al. [32] , which based on the shell system from the myxobacterium Haliangium ochraceum (HO-shell) (Figure 3A). The HO-shell is able to assemble without containing any cargo molecule inside [32][35] and is built by the shell proteins BMC-H, BMC-P and three BMC-T proteins (single-layer T1, and double-layer T2 and T3). The synthetic BMC shell, designed by the Kerfeld lab can form without the presence of the BMC-P proteins (Figure 3B) [29][36]. Without the pentamers, there are pores left that allow molecules to diffuse in/out of the lumen of the BMC. This form of the synthetic BMC is called full wiffleball. An even more simplified shell (minimal wiffleball) was designed to consist only two shell proteins, BMC-H and BMC-T1 (Figure 3C).

Synthetic BMCs serve as autonomous metabolic modules, which are decoupled from the regulatory mechanisms of the cell and are only connected to the metabolism of the cell via the engineered protein envelope [32].

Variations of the compartment structure showing the different components

Figure 2: Variations of the compartment structure showing the different components: (blue: P protein; yellow: H protein; pink: T1 protein; violet: T2/T3). The representation is based on the model of the Kerfeld group [32] (structure from PDB: 6MZX). Figure created with PyMOL.

In order to target enzymes into the shell, the SpyCatcher/SpyTag and SnoopCatcher/SnoopTag systems were used to covalently bind a cargo to the inside of the shell. The Spy/SnoopTag is a small peptide that spontaneously reacts with the protein, Spy/SnoopCatcher, to form an intermolecular isopeptide bond between the pair [37] . To precisely encapsulate two distinct cargo proteins into the lumen of a synthetic BMC, both, SpyTag and SnoopTag, are incorporated into a lumen-facing loop of the BMC-T1 shell protein. The respective catcher is attached to the N- or C-terminal region of distinct target proteins [32].

2. Encapsulins are nanocompartments, which similar to microcompartments, are self-assembled protein compartments, natively found in some bacteria and archaea [38]. They can be distinguished from microcompartments through the size of the compartments (20-42 nm) [38]. The encapsulins from Thermotoga maritima and Mycobacterium tuberculosis have outer diameters of 20–24 nm and are composed of 60 identical encapsulin protein subunits. The largest encapsulin compartment discovered to date is represented by that of Quasibacillus thermotolerans with a 42 nm outer diameter and 240 identical subunits [39]. Structural experiments showed that encapsulins are icosahedral shell-like protein compartments resembling viral capsids (Hong Kong 97‐like fold) [39][40]. The pore size of ~5 Å allows channelling small molecular substrates through the shell. Multiple encapsulins encapsulate cargo protein based on a short C-terminal peptide sequence, called the targeting peptide (TP) [38]. TPs often include a specific anchoring sequence, such as the Gly–Ser–Leu singlet or doublet motif and binding is mediated by hydrophobic and ionic interactions [41][42]. Encapsulins have attracted the attention of the synthetic biology community for the possibility of engineering small protein nanocages e.g. for drug delivery [43]. The encapsulins are highly suitable for such purposes given their high stability at high temperatures and various pH levels [44]. For our project, we decided to use an encapsulin derived from M. xanthus which is composed of the protein EncA, forming the shell (Figure 4) [40][45].

Encapsulin of the organism M. xanthus, which is composed of the protein EncA.

Figure 3: Encapsulin of the organism M. xanthus, which is composed of the protein EncA. Encapsulin compartments can provide stabilization and co-localization of cargo proteins and can also be engineered to encapsulate non-native enzymes, as previously shown in yeast (structure from PDB: 4PT2). Figure created with PyMOL.

In M. xanthus, the encapsulin is known to encapsulate three different cargo proteins, which play a role in iron storage [45]. This specific encapsulin was deemed a great fit for our team, as it has previously been engineered to encapsulate non-native enzymes in yeast [46].

3. Self-assembling proteins such as the spindle-deficient protein 5 (SPD-5) derived from Caenorhabditis elegans can form spontaneously, assembling dynamic organelles in vitro and in vivo [47]. Not only does SPD-5 reliably form droplet-like structures even in the highly crowded environment of the cytoplasm, but it also has been shown to naturally recruit enzymes and related molecules into the dynamic formation [48][49]. SPD-5 contains nine predicted coiled-coil domains, which make up ~40% of the protein. Studies have shown that the coiled-coil domains are involved in the formation of stoichiometric protein complexes and drive the formation of amorphous condensates followed by a rearrangement stage. SPD-5 condensates form as viscous liquids that quickly harden [48]. Even though SPD-5 is dynamic and does not permit exclusive entry and exit of specific molecules, it has been successfully used to enhance the efficiency of reactions, for example, by improving non-canonical amino acid incorporation with an orthogonal translation system ([50] and iGEM Freiburg 2019). In order to target cargos specifically to liquid droplets the SpyCatcher/SpyTag and SnoopCatcher/SnoopTag systems (explained above) was applied to enhance the property SPD-5 based compartments.

Getting to the other pages

References


[1] Y. G. Zhao and H. Zhang, “Phase Separation in Membrane Biology: The Interplay between Membrane-Bound Organelles and Membraneless Condensates,” Dev. Cell, vol. 55, no. 1, pp. 30–44, 2020, doi: 10.1016/j.devcel.2020.06.033.
[2] E. Gomes and J. Shorter, “The molecular language of membraneless organelles,” J. Biol. Chem., vol. 294, no. 18, pp. 7115–7127, 2019, doi: 10.1074/jbc.TM118.001192.
[3] J. M. Volland et al., “A centimeter-long bacterium with DNA contained in metabolically active, membrane-bound organelles,” Science (80-. )., vol. 376, no. 6600, pp. 1453–1458, 2022, doi: https://doi.org/10.1101/2022.02.16.480423.
[4] C. A. Kerfeld, C. Aussignargues, J. Zarzycki, F. Cai, and M. Sutter, “Bacterial microcompartments,” Nat. Rev. Microbiol., vol. 16, no. 5, pp. 277–290, 2018, doi: 10.1038/nrmicro.2018.10.
[5] A. H. Chen and P. A. Silver, “Designing biological compartmentalization,” Trends Cell Biol., vol. 22, no. 12, pp. 662–670, 2012, doi: 10.1016/j.tcb.2012.07.002.
[6] A. M. Ladouceur et al., “Clusters of bacterial RNA polymerase are biomolecular condensates that assemble through liquid-liquid phase separation,” Proc. Natl. Acad. Sci. U. S. A., vol. 117, no. 31, pp. 18540–18549, 2020, doi: 10.1073/pnas.2005019117.
[7] B. Guilhas et al., “ATP-Driven Separation of Liquid Phase Condensates in Bacteria,” Mol. Cell, vol. 79, no. 2, pp. 293-303.e4, 2020, doi: 10.1016/j.molcel.2020.06.034.
[8] N. Al-Husini, D. T. Tomares, O. Bitar, W. S. Childers, and J. M. Schrader, “α-Proteobacterial RNA Degradosomes Assemble Liquid-Liquid Phase-Separated RNP Bodies,” Mol. Cell, vol. 71, no. 6, pp. 1027-1039.e14, 2018, doi: 10.1016/j.molcel.2018.08.003.
[9] X. Jin et al., “Membraneless organelles formed by liquid-liquid phase separation increase bacterial fitness,” Sci. Adv., vol. 7, no. 43, 2021, doi: 10.1126/sciadv.abh2929.
[10] W. Bonacci et al., “Modularity of a carbon-fixing protein organelle,” Proc. Natl. Acad. Sci. U. S. A., vol. 109, no. 2, pp. 478–483, 2012, doi: 10.1073/pnas.1108557109.
[11] B. B. Menon, Z. Dou, S. Heinhorst, J. M. Shively, and G. C. Cannon, “Halothiobacillus neapolitanus carboxysomes sequester heterologous and chimeric RubisCO species,” PLoS One, vol. 3, no. 10, 2008, doi: 10.1371/journal.pone.0003570.
[12] D. F. Savage, B. Afonso, A. H. Chen, and P. A. Silver, “Bacterial Carbon Fixation Machinery,” Science (80-. )., vol. 327, no. March, pp. 1258–1261, 2010.
[13] M. Fischbach and C. A. Voigt, “Prokaryotic gene clusters: A rich toolbox for synthetic biology,” Biotechnol. J., vol. 5, no. 12, pp. 1277–1296, 2010, doi: 10.1002/biot.201000181.
[14] H. Chen, J. Wilson, S. Ottinger, Q. Gan, and C. Fan, “Introducing noncanonical amino acids for studying and engineering bacterial microcompartments,” Curr. Opin. Microbiol., vol. 61, pp. 67–72, 2021, doi: 10.1016/j.mib.2021.03.004.
[15] J. C. Jackson, S. P. Duffy, K. R. Hess, and R. A. Mehl, “Improving nature’s enzyme active site with genetically encoded unnatural amino acids,” J. Am. Chem. Soc., vol. 128, no. 34, pp. 11124–11127, 2006, doi: 10.1021/ja061099y.
[16] I. Drienovská and G. Roelfes, “Expanding the enzyme universe with genetically encoded unnatural amino acids,” Nat. Catal., vol. 3, no. 3, pp. 193–202, 2020, doi: 10.1038/s41929-019-0410-8.
[17] D. Choe, S. Cho, S. C. Kim, and B. K. Cho, “Minimal genome: Worthwhile or worthless efforts toward being smaller?,” Biotechnol. J., vol. 11, no. 2, pp. 199–211, 2016, doi: 10.1002/biot.201400838.
[18] M. McNutt, “Climate change impacts,” Science (80-. )., vol. 341, no. 6145, p. 435, 2013, doi: 10.1126/science.1243256.
[19] F. Johnsson, J. Kjärstad, and J. Rootzén, “The threat to climate change mitigation posed by the abundance of fossil fuels,” Clim. Policy, vol. 19, no. 2, pp. 258–274, 2019, doi: 10.1080/14693062.2018.1483885.
[20] M. Höök and X. Tang, “Depletion of fossil fuels and anthropogenic climate change-A review,” Energy Policy, vol. 52, pp. 797–809, 2013, doi: 10.1016/j.enpol.2012.10.046.
[21] J. Du, Z. Shao, and H. Zhao, “Engineering microbial factories for synthesis of value-added products,” J. Ind. Microbiol. Biotechnol., vol. 38, no. 8, pp. 873–890, 2011, doi: 10.1007/s10295-011-0970-3.
[22] N. Ferrer-Miralles, J. Domingo-Espín, J. Corchero, E. Vázquez, and A. Villaverde, “Microbial factories for recombinant pharmaceuticals,” Microb. Cell Fact., vol. 8, pp. 1–8, 2009, doi: 10.1186/1475-2859-8-17.
[23] L. Sanchez-Garcia, L. Martín, R. Mangues, N. Ferrer-Miralles, E. Vázquez, and A. Villaverde, “Recombinant pharmaceuticals from microbial cells: A 2015 update,” Microb. Cell Fact., vol. 15, no. 1, pp. 1–7, 2016, doi: 10.1186/s12934-016-0437-3.
[24] S. C. Wenzel and R. Müller, “Myxobacteria - ‘microbial factories’ for the production of bioactive secondary metabolites,” Mol. Biosyst., vol. 5, no. 6, pp. 567–574, 2009, doi: 10.1039/b901287g.
[25] N. S. Lau, M. Matsui, and A. A. A. Abdullah, “Cyanobacteria: Photoautotrophic Microbial Factories for the Sustainable Synthesis of Industrial Products,” Biomed Res. Int., vol. 2015, 2015, doi: 10.1155/2015/754934.
[26] E. Cornejo, N. Abreu, and A. Komeili, “Compartmentalization and organelle formation in bacteria,” Curr. Opin. Cell Biol., vol. 26, no. 1, pp. 132–138, Feb. 2014, doi: 10.1016/j.ceb.2013.12.007.
[27] T. W. Giessen and P. A. Silver, “Encapsulation as a Strategy for the Design of Biological Compartmentalization,” J. Mol. Biol., vol. 428, no. 5, pp. 916–927, 2016, doi: 10.1016/j.jmb.2015.09.009.
[28] W. Martin, “Evolutionary origins of metabolic compartmentalization in eukaryotes,” Philos. Trans. R. Soc. B Biol. Sci., vol. 365, no. 1541, pp. 847–855, 2010, doi: 10.1098/rstb.2009.0252.
[29] H. Kirst and C. A. Kerfeld, “Bacterial microcompartments: Catalysis-enhancing metabolic modules for next generation metabolic and biomedical engineering,” BMC Biol., vol. 17, no. 1, pp. 1–11, 2019, doi: 10.1186/s12915-019-0691-z.
[30] C. M. Agapakis, P. M. Boyle, and P. A. Silver, “Natural strategies for the spatial optimization of metabolism in synthetic biology,” Nat. Chem. Biol., vol. 8, no. 6, pp. 527–535, 2012, doi: 10.1038/nchembio.975.
[31] C. Liu et al., “Metabolic Engineering Mevalonate Pathway Mediated by RNA Scaffolds for Mevalonate and Isoprene Production in,” 2022, doi: 10.1021/acssynbio.2c00226.
[32] H. Kirst, B. H. Ferlez, S. N. Lindner, C. A. R. Cotton, A. Bar-Even, and C. A. Kerfeld, “Toward a glycyl radical enzyme containing synthetic bacterial microcompartment to produce pyruvate from formate and acetate,” Proc. Natl. Acad. Sci. U. S. A., vol. 119, no. 8, pp. 1–10, 2022, doi: 10.1073/pnas.2116871119.
[33] M. G. Klein et al., “Identification and Structural Analysis of a Novel Carboxysome Shell Protein with Implications for Metabolite Transport,” J. Mol. Biol., vol. 392, no. 2, pp. 319–333, 2009, doi: 10.1016/j.jmb.2009.03.056.
[34] M. J. Lee, D. J. Palmer, and M. J. Warren, “Biotechnological Advances in Bacterial Microcompartment Technology,” Trends Biotechnol., vol. 37, no. 3, pp. 325–336, 2019, doi: 10.1016/j.tibtech.2018.08.006.
[35] J. K. Lassila, S. L. Bernstein, J. N. Kinney, S. D. Axen, and C. A. Kerfeld, “Assembly of robust bacterial microcompartment shells using building blocks from an organelle of unknown function,” J. Mol. Biol., vol. 426, no. 11, pp. 2217–2228, 2014, doi: 10.1016/j.jmb.2014.02.025.
[36] A. Hagen, M. Sutter, N. Sloan, and C. A. Kerfeld, “Programmed loading and rapid purification of engineered bacterial microcompartment shells,” Nat. Commun., vol. 9, no. 1, pp. 1–10, 2018, doi: 10.1038/s41467-018-05162-z.
[37] B. Zakeri et al., “Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin,” Proc. Natl. Acad. Sci. U. S. A., vol. 109, no. 12, 2012, doi: 10.1073/pnas.1115485109.
[38] T. W. Giessen, “Encapsulins: Microbial nanocompartments with applications in biomedicine, nanobiotechnology and materials science,” Curr. Opin. Chem. Biol., vol. 34, pp. 1–10, 2016, doi: 10.1016/j.cbpa.2016.05.013.
[39] J. A. Jones and T. W. Giessen, “Advances in encapsulin nanocompartment biology and engineering,” Biotechnol. Bioeng., vol. 118, no. 1, pp. 491–505, 2021, doi: 10.1002/bit.27564.
[40] J. Fontana et al., “Phage capsid-like structure of Myxococcus xanthus encapsulin, a protein shell that stores iron,” Microsc. Microanal., vol. 20, no. 3, pp. 1244–1245, 2014, doi: 10.1017/S1431927614007958.
[41] M. Sutter et al., “Structural basis of enzyme encapsulation into a bacterial nanocompartment,” Nat. Struct. Mol. Biol., vol. 15, no. 9, pp. 939–947, 2008, doi: 10.1038/nsmb.1473.
[42] W. J. Altenburg, N. Rollins, P. A. Silver, and T. W. Giessen, “Exploring targeting peptide-shell interactions in encapsulin nanocompartments,” Sci. Rep., vol. 11, no. 1, pp. 1–9, 2021, doi: 10.1038/s41598-021-84329-z.
[43] A. Van de Steen et al., “Bioengineering bacterial encapsulin nanocompartments as targeted drug delivery system,” Synth. Syst. Biotechnol., vol. 6, no. 3, pp. 231–241, 2021, doi: 10.1016/j.synbio.2021.09.001.
[44] I. Boyton, S. C. Goodchild, D. Diaz, A. Elbourne, L. Collins-Praino, and A. Care, “Exploring the Self-Assembly of Encapsulin Protein Nanocages from Different Structural Classes,” bioRxiv, 2021, doi: 10.1101/2021.06.06.447285.
[45] C. A. McHugh et al., “A virus capsid‐like nanocompartment that stores iron and protects bacteria from oxidative stress,” EMBO J., vol. 33, no. 17, pp. 1896–1911, 2014, doi: 10.15252/embj.201488566.
[46] Y. H. Lau, T. W. Giessen, W. J. Altenburg, and P. A. Silver, “Prokaryotic nanocompartments form synthetic organelles in a eukaryote,” Nat. Commun., vol. 9, no. 1, 2018, doi: 10.1038/s41467-018-03768-x.
[47] D. R. Hamill, A. F. Severson, J. C. Carter, and B. Bowerman, “Centrosome maturation and mitotic spindle assembly in C. elegans require SPD-5, a protein with multiple coiled-coil domains,” Dev. Cell, vol. 3, no. 5, pp. 673–684, 2002, doi: 10.1016/S1534-5807(02)00327-1.
[48] J. B. Woodruff, B. Ferreira Gomes, P. O. Widlund, J. Mahamid, A. Honigmann, and A. A. Hyman, “The Centrosome Is a Selective Condensate that Nucleates Microtubules by Concentrating Tubulin,” Cell, vol. 169, no. 6, pp. 1066-1077.e10, 2017, doi: 10.1016/j.cell.2017.05.028.
[49] A. K. Tiwary and Y. Zheng, “Protein phase separation in mitosis,” Curr. Opin. Cell Biol., vol. 60, no. 1, pp. 92–98, Oct. 2019, doi: 10.1016/j.ceb.2019.04.011.
[50] C. D. Reinkemeier, G. E. Girona, and E. A. Lemke, “Designer membraneless organelles enable codon reassignment of selected mRNAs in eukaryotes,” Science (80-. )., vol. 363, no. 6434, 2019, doi: 10.1126/science.aaw2644.
[51] L. Wang, A. Brock, B. Herberich, and P. G. Schultz, “Expanding the Genetic Code of Escherichia coli,” Science (80-. )., vol. 292, no. 5516, pp. 498–500, Apr. 2001, doi: 10.1126/science.1060077.
[52] M. Amiram et al., “Evolution of translation machinery in recoded bacteria enables multi-site incorporation of nonstandard amino acids,” Nat. Biotechnol., vol. 33, no. 12, pp. 1272–1279, 2015, doi: 10.1038/nbt.3372.
[53] L. Wang and P. G. Schultz, “A general approach for the generation of orthogonal tRNAs,” Chem. Biol., vol. 8, no. 9, pp. 883–890, 2001, doi: 10.1016/S1074-5521(01)00063-1.
[54] E. C. Fischer et al., “New codons for efficient production of unnatural proteins in a semisynthetic organism,” Nat. Chem. Biol., vol. 16, no. 5, pp. 570–576, 2020, doi: 10.1038/s41589-020-0507-z.
[55] K. C. Schultz, L. Supekova, Y. Ryu, J. Xie, R. Perera, and P. G. Schultz, “A genetically encoded infrared probe,” J. Am. Chem. Soc., vol. 128, no. 43, pp. 13984–13985, 2006, doi: 10.1021/ja0636690.
[56] Y. Won, A. D. Pagar, M. D. Patil, P. E. Dawson, and H. Yun, “Recent Advances in Enzyme Engineering through Incorporation of Unnatural Amino Acids,” Biotechnol. Bioprocess Eng., vol. 24, no. 4, pp. 592–604, 2019, doi: 10.1007/s12257-019-0163-x.
[57] Q. Gan, B. P. Lehman, T. A. Bobik, and C. Fan, “Expanding the genetic code of Salmonella with non-canonical amino acids,” Sci. Rep., vol. 6, no. November, pp. 1–7, 2016, doi: 10.1038/srep39920.
[58] K. J. Lee, D. Kang, and H. S. Park, “Site-Specific Labeling of Proteins Using Unnatural Amino Acids,” Mol. Cells, vol. 42, no. 5, pp. 386–396, 2019, doi: 10.14348/molcells.2019.0078.
[59] N. D. Pham, R. B. Parker, and J. J. Kohler, “Photocrosslinking approaches to interactome mapping,” Curr. Opin. Chem. Biol., vol. 17, no. 1, pp. 90–101, 2013, doi: 10.1016/j.cbpa.2012.10.034.
[60] N. Wenner, “The Production of Indigo Dye from Plants,” Fibershed, no. December, pp. 1–13, 2017, [Online]. Available: https://bit.ly/3ymh4Xp.
[61] T. M. Hsu et al., “Sustainable Indigo Dyeing Strategy,” Nat. Publ. Gr., vol. 14, no. january, pp. 256–261, 2018, doi: 10.1038/nchembio.2552.Employing.
[62] K. Aino, K. Hirota, T. Okamoto, Z. Tu, H. Matsuyama, and I. Yumoto, “Microbial communities associated with indigo fermentation that thrive in anaerobic alkaline environments,” Front. Microbiol., vol. 9, no. SEP, pp. 1–16, 2018, doi: 10.3389/fmicb.2018.02196.
[63] S. Bhatt, A. Anyanful, and D. Kalman, “CsrA and TnaB coregulate tryptophanase activity to promote exotoxin-induced killing of Caenorhabditis elegans by enteropathogenic Escherichia coli,” J. Bacteriol., vol. 193, no. 17, pp. 4516–4522, 2011, doi: 10.1128/JB.05197-11.
[64] G. Li and K. D. Young, “Indole production by the tryptophanase TnaA in escherichia coli is determined by the amount of exogenous tryptophan,” Microbiol. (United Kingdom), vol. 159, no. 2, pp. 402–410, 2013, doi: 10.1099/mic.0.064139-0.
[65] H. Yin et al., “Efficient Bioproduction of Indigo and Indirubin by Optimizing a Novel Terpenoid Cyclase XiaI in Escherichia coli,” ACS Omega, vol. 6, no. 31, pp. 20569–20576, 2021, doi: 10.1021/acsomega.1c02679.
[66] S. Nam et al., “Indirubin derivatives induce apoptosis of chronic myelogenous leukemia cells involving inhibition of Stat5 signaling,” Mol. Oncol., vol. 6, no. 3, pp. 276–283, 2012, doi: 10.1016/j.molonc.2012.02.002.
[67] A. B. Richards et al., “Trehalose: A review of properties, history of use and human tolerance, and results of multiple safety studies,” Food Chem. Toxicol., vol. 40, no. 7, pp. 871–898, 2002, doi: 10.1016/S0278-6915(02)00011-X.
[68] H. Li et al., “Enhanced production of trehalose in Escherichia coli by homologous expression of otsBA in the presence of the trehalase inhibitor, validamycin A, at high osmolarity,” J. Biosci. Bioeng., vol. 113, no. 2, pp. 224–232, 2012, doi: 10.1016/j.jbiosc.2011.09.018.
[69] C. Schiraldi, I. Di Lernia, and M. De Rosa, “Trehalose production: Exploiting novel approaches,” Trends Biotechnol., vol. 20, no. 10, pp. 420–425, 2002, doi: 10.1016/S0167-7799(02)02041-3.
[70] R. Ruhal, R. Kataria, and B. Choudhury, “Trends in bacterial trehalose metabolism and significant nodes of metabolic pathway in the direction of trehalose accumulation,” Microb. Biotechnol., vol. 6, no. 5, pp. 493–502, 2013, doi: 10.1111/1751-7915.12029.
[71] G. Iturriaga, R. Suárez, and B. Nova-Franco, “Trehalose metabolism: From osmoprotection to signaling,” Int. J. Mol. Sci., vol. 10, no. 9, pp. 3793–3810, 2009, doi: 10.3390/ijms10093793.
[72] A. R. Strom and I. Kaasen, “Trehalose metabolism in Escherichia coli: stress protection and stress regulation of gene expression,” Mol. Microbiol., vol. 8, no. 2, pp. 205–210, 1993, doi: 10.1111/j.1365-2958.1993.tb01564.x.
[73] A. Patist and H. Zoerb, “Preservation mechanisms of trehalose in food and biosystems,” Colloids Surfaces B Biointerfaces, vol. 40, no. 2, pp. 107–113, 2005, doi: 10.1016/j.colsurfb.2004.05.003.
[74] R. J. Dutton, D. Boyd, M. Berkmen, and J. Beckwith, “Bacterial species exhibit diversity in their mechanisms and capacity for protein disulfide bond formation,” Proc. Natl. Acad. Sci. U. S. A., vol. 105, no. 33, pp. 11933–11938, 2008, doi: 10.1073/pnas.0804621105.
[75] D. Hatlem, T. Trunk, D. Linke, and J. C. Leo, “Catching a SPY: Using the SpyCatcher-SpyTag and related systems for labeling and localizing bacterial proteins,” Int. J. Mol. Sci., vol. 20, no. 9, 2019, doi: 10.3390/ijms20092129.
[76] H. J. Kang and E. N. Baker, “Intramolecular isopeptide bonds: Protein crosslinks built for stress?,” Trends Biochem. Sci., vol. 36, no. 4, pp. 229–237, 2011, doi: 10.1016/j.tibs.2010.09.007.
[77] G. Veggiani et al., “Programmable polyproteams built using twin peptide superglues,” Proc. Natl. Acad. Sci. U. S. A., vol. 113, no. 5, pp. 1202–1207, 2016, doi: 10.1073/pnas.1519214113.
[78] S. A. H. Heyde and M. H. H. Nørholm, “Tailoring the evolution of BL21(DE3) uncovers a key role for RNA stability in gene expression toxicity,” Commun. Biol., vol. 4, no. 1, pp. 1–9, 2021, doi: 10.1038/s42003-021-02493-4.
[79] H. Jeong et al., “Genome Sequences of Escherichia coli B strains REL606 and BL21(DE3),” J. Mol. Biol., vol. 394, no. 4, pp. 644–652, 2009, doi: 10.1016/j.jmb.2009.09.052.
[80] G. L. Rosano, E. S. Morales, and E. A. Ceccarelli, “New tools for recombinant protein production in Escherichia coli: A 5-year update,” Protein Sci., vol. 28, no. 8, pp. 1412–1422, 2019, doi: 10.1002/pro.3668.
[81] L. A. Burdette, S. A. Leach, H. T. Wong, and D. Tullman-Ercek, “Developing Gram-negative bacteria for the secretion of heterologous proteins,” Microb. Cell Fact., vol. 17, no. 1, pp. 1–16, 2018, doi: 10.1186/s12934-018-1041-5.
[82] G. Lozano Terol, J. Gallego-Jara, R. A. Sola Martínez, A. Martínez Vivancos, M. Cánovas Díaz, and T. de Diego Puente, “Impact of the Expression System on Recombinant Protein Production in Escherichia coli BL21,” Front. Microbiol., vol. 12, no. June, pp. 1–12, 2021, doi: 10.3389/fmicb.2021.682001.
[83] F. R. Blattner et al., “The complete genome sequence of Escherichia coli K-12,” Science (80-. )., vol. 277, no. 5331, pp. 1453–1462, 1997, doi: 10.1126/science.277.5331.1453.
[84] M. J. Lajoie et al., “Genomically Recoded Organisms Expand Biological Functions,” Science (80-. )., vol. 342, no. 6156, pp. 357–360, Oct. 2013, doi: 10.1126/science.1241459.
[85] K. Dryden, D. Lina, and N. Fabris, “Minicells from Highly Genome Reduced,” 2021.
[86] M. Kurokawa and B. W. Ying, “Experimental challenges for reduced genomes: The cell model escherichia coli,” Microorganisms, vol. 8, no. 1, 2020, doi: 10.3390/microorganisms8010003.
[87] C. Pál, B. Papp, and G. Pósfai, “The dawn of evolutionary genome engineering,” Nat. Rev. Genet., vol. 15, no. 7, pp. 504–512, 2014, doi: 10.1038/nrg3746.
[88] S. M. Chiang and H. E. Schellhorn, “Regulators of oxidative stress response genes in Escherichia coli and their functional conservation in bacteria,” Arch. Biochem. Biophys., vol. 525, no. 2, pp. 161–169, 2012, doi: 10.1016/j.abb.2012.02.007.
[89] S. Babakhani and M. Oloomi, “Transposons: the agents of antibiotic resistance in bacteria,” J. Basic Microbiol., vol. 58, no. 11, pp. 905–917, 2018, doi: 10.1002/jobm.201800204.
[90] S. Müller, H. Harms, and T. Bley, “Origin and analysis of microbial population heterogeneity in bioprocesses,” Curr. Opin. Biotechnol., vol. 21, no. 1, pp. 100–113, 2010, doi: 10.1016/j.copbio.2010.01.002.
[91] P. Rugbjerg, N. Myling-Petersen, A. Porse, K. Sarup-Lytzen, and M. O. A. Sommer, “Diverse genetic error modes constrain large-scale bio-based production,” Nat. Commun., vol. 9, no. 1, 2018, doi: 10.1038/s41467-018-03232-w.
[92] S. J. Giovannoni et al., “Genetics: Genome streamlining in a cosmopolitan oceanic bacterium,” Science (80-. )., vol. 309, no. 5738, pp. 1242–1245, 2005, doi: 10.1126/science.1114057.
[93] D. J. Martínez-Cano et al., “Evolution of small prokaryotic genomes,” Front. Microbiol., vol. 6, no. JAN, pp. 1–23, 2015, doi: 10.3389/fmicb.2014.00742.
[94] M. Kafri, E. Metzl-Raz, G. Jona, and N. Barkai, “The Cost of Protein Production,” Cell Rep., vol. 14, no. 1, pp. 22–31, 2016, doi: 10.1016/j.celrep.2015.12.015.
[95] M. Juhas, D. R. Reuß, B. Zhu, and F. M. Commichau, “Bacillus subtilis and Escherichia coli essential genes and minimal cell factories after one decade of genome engineering,” Microbiol. (United Kingdom), vol. 160, pp. 2341–2351, 2014, doi: 10.1099/mic.0.079376-0.
[96] J. H. Lee et al., “Metabolic engineering of a reduced-genome strain of Escherichia coli for L-threonine production,” Microb. Cell Fact., vol. 8, no. 1, pp. 1–12, 2009, doi: 10.1186/1475-2859-8-2.
[97] M. Hashimoto et al., “Cell size and nucleoid organization of engineered Escherichia coli cells with a reduced genome,” Mol. Microbiol., vol. 55, no. 1, pp. 137–149, 2005, doi: 10.1111/j.1365-2958.2004.04386.x.
[98] H. Yu et al., “Minicells from Highly Genome Reduced Escherichia coli: Cytoplasmic and Surface Expression of Recombinant Proteins and Incorporation in the Minicells,” ACS Synth. Biol., vol. 10, no. 10, pp. 2465–2477, 2021, doi: 10.1021/acssynbio.1c00375.
[99] J. I. Kato and M. Hashimoto, “Construction of consecutive deletions of the Escherichia coli chromosome,” Mol. Syst. Biol., vol. 3, no. 132, pp. 1–7, 2007, doi: 10.1038/msb4100174.
[100] G. Pósfai, K. Umenhoffer, V. Kolisnychenko, B. Stahl, and S. S. Sharma, “Emergent Properties of,” vol. 1044, no. 2006, pp. 1044–1047, 2013.